| Evaluation of the Use of Granulocyte Colony Stimulating Factor (GCSF) in Post Kasai Type 3 Biliary Atresia (NCT06708572) | National Liver Institute, Egypt | 2024-12-01 |
| CBD Stenting vs Non-Stenting for Choledocholithiasis (NCT07331142) | National Liver Institute, Egypt | 2024-03-01 |
| Immediate vs. Elective Endoscopic Removal of Large CBD Stones in High-Risk Elderly Patients (NCT06948279) | National Liver Institute, Egypt | 2022-02-01 |
| Double Stent for Biliary Stones in Cirrhotic Patients (NCT07337291) | National Liver Institute, Egypt | 2022-01-01 |
| Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management (NCT05184491) | National Liver Institute, Egypt | 2021-10-15 |
| Proton Pump Inhibitors in Cirrhotic Patients (NCT06384443) | National Liver Institute, Egypt | 2020-10-01 |
| Safety and Efficacy of Midodrine Hydrochloride in the Management of Refractory Ascites Due to Cirrhosis in Children (NCT04043858) | National Liver Institute, Egypt | 2020-06-05 |
| Ultrasonography for Nutritional Assesment in Cirrhotic Patients (NCT04099875) | National Liver Institute, Egypt | 2019-04-01 |
| Eight Weeks Sofosbovir/Ledipasvir in HCV Infected Children Aged 4 to 10 Years (NCT03764345) | National Liver Institute, Egypt | 2018-12-06 |
| Role of Oral Zinc in Reducing Neonatal Indirect Hyperbilirubinemia (NCT06227624) | National Liver Institute, Egypt | 2018-06-01 |